Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Merino

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Communications Medicine|November 20, 2025
Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRIFrancesco Grussu, Athanasios Grigoriou, Kinga Bernatowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)Jaume Capdevila, Nicola Fazio, Carlos Lopez, et al.
Nature Communications|November 28, 2025
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosisAlberto Langtry, Raul Rabadan, Lola Alonso, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Communications Medicine|November 20, 2025
Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRIFrancesco Grussu, Athanasios Grigoriou, Kinga Bernatowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)Jaume Capdevila, Nicola Fazio, Carlos Lopez, et al.
Nature Communications|November 28, 2025
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosisAlberto Langtry, Raul Rabadan, Lola Alonso, et al.
Pageof 3